Skip to main content
رجوع
Watch Compare

Neumora Therapeutics, Inc.

جودة البيانات: 83%
NMRA
Nasdaq Manufacturing Chemicals
KWD 2.08
▼ KWD 0.10 (-4.59%)
القيمة السوقية: 378.65 M
السعر
KWD 2.08
القيمة السوقية
378.65 M
نطاق اليوم
KWD 2.05 — KWD 2.16
نطاق 52 أسبوعًا
KWD 0.61 — KWD 3.65
حجم التداول
634,662
فتح KWD 2.16
متوسط 50 يوم / 200 يوم
KWD 2.71
23.38% below
متوسط 50 يوم / 200 يوم
KWD 2.07
0.47% above

Quick Summary

النقاط الرئيسية

Debt/Equity of 0.15 — conservative balance sheet
Negative free cash flow of -206.44 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-150.41%
أقل من متوسط القطاع (-51.02%)
ROIC-107.43%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.15
أقل من متوسط القطاع (0.33)
Current Ratio6.85
Interest Coverage-119.98

التقييم

PE (TTM)
-1.60
أعلى من متوسط القطاع (-1.98)
P/B Ratio2.87
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -1.6 -2.0
P/B 2.9 5.1
ROE % -150.4 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E 0.2 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -236.93 M
ROE -150.41% ROA -117.97%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -206.44 M
ROIC -107.43% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.15 Current Ratio 6.85
Interest Coverage -119.98 Asset Turnover N/A
Working Capital 151.24 M Tangible Book Value 132.16 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.60 Forward P/E N/A
P/B Ratio 2.87 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -54.52%
Market Cap 378.65 M Enterprise Value 269.14 M
Per Share
EPS (Diluted TTM) -1.45 Revenue / Share N/A
FCF / Share -1.13 OCF / Share -1.13
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 87.13%
SBC-Adj. FCF -238.86 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -236.93 M -243.79 M -235.93 M
EPS (Diluted) -1.45 -1.53 -3.63
Gross Profit — — —
Operating Income -241.16 M -263.46 M -252.10 M
EBITDA — — —
R&D Expenses 176.07 M 200.93 M 142.72 M
SG&A Expenses — — —
D&A 208,000.0 631,000.0 668,000.0
Interest Expense 2.01 M — —
Income Tax 130,000.0 178,000.0 268,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 191.05 M 316.97 M 496.20 M
Total Liabilities 87.18 M 29.91 M 27.12 M
Shareholders' Equity 103.87 M 287.06 M 469.08 M
Total Debt 54.53 M — —
Cash & Equivalents 182.53 M 142.15 M 374.04 M
Current Assets 190.54 M 314.06 M 478.28 M
Current Liabilities 32.45 M 29.89 M 25.11 M